These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31339231)

  • 1. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
    Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.
    John R; Kurian JJ; Sen S; Gupta MK; Jehangir S; Mathew LG; Mathai J
    J Pediatr Urol; 2018 Dec; 14(6):547.e1-547.e7. PubMed ID: 30017606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG).
    Sudour-Bonnange H; van Tinteren H; Ramírez-Villar GL; Godzinski J; Irtan S; Gessler M; Chowdhury T; Audry G; Fuchs J; Powis M; van de Ven CP; Okoye B; Smeulders N; Vujanic GM; Verschuur A; L'Herminé-Coulomb A; de Camargo B; de Aguirre Neto JC; Schenk JP; van den Heuvel-Eibrink MM; Pritchard-Jones K; Graf N; Bergeron C; Furtwängler R
    Br J Cancer; 2024 Oct; 131(6):972-981. PubMed ID: 39080350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
    Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
    J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
    de Kraker J; Graf N; van Tinteren H; Pein F; Sandstedt B; Godzinski J; Tournade MF;
    Lancet; 2004 Oct 2-8; 364(9441):1229-35. PubMed ID: 15464183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Nephroblastoma Treatment According to the SIOP-2001 Strategy at a Single Institution in Argentina.
    Cafferata C; Cacciavillano W; Galluzzo ML; Flores P; Rose A; Zubizarreta P
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):50-55. PubMed ID: 27379530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemotherapy in the management of intracaval extension of Wilms' tumor.
    Crombleholme TM; Jacir NN; Rosenfield CG; Lew S; Harris BH
    J Pediatr Surg; 1994 Feb; 29(2):229-31. PubMed ID: 8176597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracaval and intracardiac extension of Wilms' tumor. The influence of preoperative chemotherapy on surgical morbidity.
    Cristofani LM; Duarte RJ; Almeida MT; Odone Filho V; Maksoud JG; Srougi M
    Int Braz J Urol; 2007; 33(5):683-9; discussion 689. PubMed ID: 17980066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of Wilms tumor with intravascular extension: a single-institution experience.
    Aspiazu D; Fernandez-Pineda I; Cabello R; Ramirez G; Alvarez-Madrid A; De Agustin JC
    Pediatr Hematol Oncol; 2012 Feb; 29(1):50-4. PubMed ID: 22304010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour.
    Israels T; Chagaluka G; Pidini D; Caron H; de Kraker J; Kamiza S; Borgstein E; Molyneux L
    Pediatr Blood Cancer; 2012 Oct; 59(4):636-41. PubMed ID: 22271712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric clear cell sarcoma of the kidney with cavoatrial thrombus.
    Sugandhi N; Munghate G; Malankar DP; Das S; Bisoi AK; Gupta AK; Agarwala S
    J Pediatr Surg; 2011 Dec; 46(12):2387-90. PubMed ID: 22152888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis.
    Boam TD; Gabriel M; Shukla R; Losty PD
    BJS Open; 2021 May; 5(3):. PubMed ID: 34052849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
    Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?
    Borgstein E; Kamiza S; Vujanic G; Pidini D; Bailey S; Tomoka T; Banda K; Kaspers G; Molyneux E; Israels T
    Pediatr Blood Cancer; 2014 Dec; 61(12):2180-4. PubMed ID: 25213396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.